| | | |  | | | | By Ed Silverman Mahesh Kumar A./AP A STAT review of documents on Bharat Biotech's Covid-19 vaccine found that regulators endorsed the vaccine despite discrepancies. Read More | | By Nicholas Florko Drew Angerer/Getty Images "We are in a very different place and we will remain in a different place. ... A large chunk of Americans have gotten infected." Read More | | By Andrew Joseph STAT At the STAT Summit, Fauci says he welcomes oversight of the government's response to the Covid pandemic and reflects on his long career. Read More | | Sponsored Insight by The University of Texas MD Anderson Cancer Center Innovative data science is driving cancer breakthroughs As a leader in cancer research, MD Anderson is committed to advancing the next wave of cancer breakthroughs. Key to this approach is harnessing the power of big data and AI-driven analytical tools to uncover new insights that can bring a deeper understanding of the disease, identify new vulnerabilities and guide more effective patient care. Exceptional data science is a core component of MD Anderson's research efforts, and active recruitment of talented individuals is underway. Learn more about available career opportunities to advance innovative cancer research. | | By Jonathan Wosen Adobe We take a close look at what has (and hasn’t) happened so far in academic science to understand what might happen next. Read More | | By Nicholas Florko Alex Hogan/STAT The FDA is supposed to police the food and drug supply. But it's easy to find illegal products — including in the FDA's own backyard. Read More | | By Katie Palmer Alex Hogan/STAT Amazon is launching Amazon Clinic, giving consumers the ability to message teleproviders and obtain prescriptions for 20 conditions. Read More | | By Ed Silverman NICHOLAS KAMM/AFP via Getty Images The prospective deal follows a deal announced earlier this month in which CVS Health and Walgreens agreed to pay about $5 billion each. Read More | | By Steve Cohen Adobe Medicare Advantage began life as a brilliant idea, but has gone off the rails. A new approach, "Part F," could revitalize the program. Read More | | By Sarah Owermohle STAT "Science and technology policy is one of the few places where one can get any kind of bipartisan cooperation." Read More | | By Megan Molteni STAT "It's important to realize that there will probably never be a perfectly specific gene-editing agent," Liu said at the 2022 STAT Summit. Read More | |
No comments